Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.

Journal article

Between August 1989 and November 2003, 33 patients at our center with acquired aplastic anemia underwent bone marrow transplantation (BMT) from HLA-identical sibling donors with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies (MoAb) for conditioning. The median age at BMT was 17 years (range, 4-46 years). Before BMT, 58% were heavily transfused (>50 transfusions), and 42% had previously experienced treatment failure with antithymocyte globulin-based immunosuppressive therapy. Unmanipulated bone marrow was used as the source of stem cells in all patients except 1. Graft-versus-host disease (GVHD) prophylaxis was with cyclosporine alone in 19 (58%) patients; 14 received anti-CD52 MoAb in addition to cyclosporine. The conditioning regimen was well tolerated without significant acute toxicity. Graft failure was seen in 8 patients (primary, n = 4; secondary, n = 4). Of those whose grafts failed, 4 survived long-term (complete autologous recovery, n = 2; rescue with previously stored marrow, n = 1; second allograft, n = 1). The cumulative incidence of graft failure and grade II to IV acute and chronic GVHD was 24%, 14%, and 4%, respectively. None developed extensive chronic GVHD. With a median follow-up of 59 months, the 5-year survival was 81% (95% confidence interval, 68%-96%). No unexpected early or late infectious or noninfectious complications were observed. We conclude that the conditioning regimen containing cyclophosphamide and anti-CD52 MoAb is well tolerated and effective for acquired aplastic anemia with HLA-matched sibling donors. The favorable effect on the incidence and severity of GVHD is noteworthy in this study and warrants further investigation.

Authors: Gupta, V; Ball, SE; Yi, Q; Sage, D; McCann, SR

• Publication status: Published
• Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
• Volume: 10
• Issue: 12
• Pages: 867-876
• Publication date: 2004-12-01
• DOI: 10.1016/j.bbmt.2004.09.001
• EISSN: 1523-6536
• ISSN: 1083-8791
• Language: English
• Keywords: Retrospective Studies; Humans; Chronic Disease; Acute Disease; Middle Aged; Antibodies, Monoclonal; Adult; Child; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Male; Transplantation Chimera; Anemia, Aplastic; Living Donors; Immunosuppressive Agents; Cyclophosphamide; Child, Preschool; Histocompatibility Testing; Glycoproteins; Survival Analysis; Graft vs Host Disease; Female; Adolescent; Siblings; Antigens, Neoplasm; Bone Marrow Transplantation; Transplantation Conditioning; Antigens, CD